tiprankstipranks
Tango Therapeutics (TNGX)
NASDAQ:TNGX
US Market
Holding TNGX?
Track your performance easily

Tango Therapeutics (TNGX) Financial Statements

302 Followers

Tango Therapeutics Financial Overview

Tango Therapeutics's market cap is currently ―. The company's EPS TTM is $-1.171; its P/E ratio is -2.88; Tango Therapeutics is scheduled to report earnings on March 31, 2025, and the estimated EPS forecast is $-0.34. See an overview of income statement, balance sheet, and cash flow financials.
Sep 24Jun 24Mar 24Dec 23Sep 23
Income Statement-
Total Revenue$ 11.61M$ 19.88M$ 6.47M$ 5.43M$ 10.73M
Gross Profit$ 11.61M$ 19.88M$ 6.47M$ 5.43M$ 10.73M
EBIT$ -30.92M$ -27.56M$ -40.51M$ -35.01M$ -24.11M
EBITDA$ -29.38M$ -25.93M$ -38.99M$ -34.40M$ -22.60M
Net Income Common Stockholders$ -29.17M$ -25.63M$ -37.91M$ -30.76M$ -22.26M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 293.28M$ 322.11M$ 343.60M$ 336.88M$ 359.88M
Total Assets$ 352.42M$ 381.45M$ 406.22M$ 402.57M$ 428.19M
Total Debt$ 37.63M$ 37.84M$ 38.23M$ 38.92M$ 39.51M
Net Debt$ -255.65M$ -284.27M$ -305.36M$ -297.96M$ -320.37M
Total Liabilities$ 123.25M$ 133.78M$ 141.77M$ 149.46M$ 151.59M
Stockholders Equity$ 229.17M$ 247.67M$ 264.45M$ 253.11M$ 276.60M
Cash Flow-
Free Cash Flow$ -33.51M$ -23.93M$ -38.05M$ -27.69M$ -31.15M
Operating Cash Flow$ -33.39M$ -23.61M$ -37.86M$ -27.47M$ -31.14M
Investing Cash Flow$ 32.57M$ 12.70M$ -11.20M$ 33.85M$ -56.66M
Financing Cash Flow$ 2.40M$ 1.31M$ 42.98M$ 1.47M$ 80.28M
Currency in USD

Tango Therapeutics Earnings and Revenue History

Tango Therapeutics Debt to Assets

Tango Therapeutics Cash Flow

Tango Therapeutics Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis